Related Experiment Videos
[Impact of platelet derived growth factor in the glomeruli of active lupus nephritis]
1Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine.
Insights
Platelet-derived growth factor (PDGF) is elevated in active lupus nephritis, correlating with hematuria. This suggests PDGF plays a key role in glomerular damage, warranting further investigation into PDGF antagonists.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Context:
- Lupus nephritis is an autoimmune disease affecting the kidneys.
- Platelet-derived growth factor (PDGF) has known biological activities and is implicated in kidney disease pathogenesis.
- The specific role of PDGF in lupus nephritis activation requires elucidation.
Purpose:
- To investigate the relationship between PDGF and disease activity in lupus nephritis.
- To quantify PDGF and its receptor expression in renal biopsies of lupus nephritis patients.
- To correlate PDGF expression with clinical markers of disease activity.
Summary:
- Immunohistochemistry and RT-PCR analysis of renal biopsies from lupus nephritis patients revealed significantly higher mRNA expression of PDGF and its receptor in cases with active glomerular lesions compared to inactive ones.
- These elevated PDGF levels paralleled the severity of hematuria.
- No correlation was found between PDGF expression and glomerular cellular proliferation.
Impact:
- These findings identify PDGF as a critical mediator in inducing active glomerular lesions in lupus nephritis.
- Suggests potential therapeutic targets for managing lupus nephritis.
- Highlights the need for further research into PDGF antagonists for glomerular damage regulation.
Abstract:
Platelet derived growth factor (PDGF) possesses diverse biological activities and plays an important role in the pathogenesis of glomeruli nephritis. In order to elucidate the relationship between PDGF and the disease activation in lupus nephritis, PDGF was observed in renal biopsy specimen from 9 cases of lupus nephritis (7 cases with active and 2 cases with inactive lesions) by immunohistochemistry using 4-layer PAP method. The mRNA expression of PDGF-A and -B chain, and the receptor of PDGF-B were analyzed by RT-PCR. It was found that the levels of mRNA expression of PDGF and its receptor were much higher in patients with active lesions in glomeruli as compared with those without active lesions, there changes were paralleled with the degree of hematuria in these patients. Noted that there was no correlation between the expression of PDGF and the cellular proliferation in glomeruli of lupus nephritis. These results indicate that PDGF is a critical mediator for inducing active lesion in glomeruli of lupus nephritis. The effect of PDGF antagonist in the regulation of glomerular damage in lupus nephritis need to further elucidate.